CCL2 and fibrosis: Fibrosis-associated biomarkers such as Matrix Metalloproteinase-7 (MMP-7), Monocyte chemoattractant protein-1 (MCP-1), and Dickkopf-3 (DKK3) have been proposed as indicators of progressive CKD, particularly in high-risk patients [5,24].